Screener
Bio-Rad Laboratories BIO Life Science — Net Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000012208-26-000035
FAQ
- What is Bio-Rad Laboratories's life science — net sales?
- Bio-Rad Laboratories (BIO) reported life science — net sales of $228.5M in Q1 2026.
- How has Bio-Rad Laboratories's life science — net sales changed year-over-year?
- Bio-Rad Laboratories's life science — net sales decreased by 0.0% year-over-year, from $228.6M to $228.5M.
- What is the long-term trend for Bio-Rad Laboratories's life science — net sales?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories's life science — net sales has grown at a -7.6% compound annual growth rate (CAGR), from $1.4B to $1.02B.
- What does life science — net sales mean?
- The total revenue generated by the Life Science segment from the sale of instruments, reagents, and services, net of returns, allowances, and discounts. This is the primary indicator of the segment's market demand and commercial success.
Ask your AI about Bio-Rad Laboratories's life science — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude